m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00656)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
TRAM2
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Browse Drug
RNA-binding motif protein 15B (RBM15B) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Overexpression of RBM15B promotes HCC cell proliferation and invasion and induces sorafenib resistance in HCC cells. RBM15B is transcriptionally activated by YY1 and regulates the stability of Translocating chain-associated membrane protein 2 (TRAM2) mRNA in an m6A-dependent manner. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Responsed Drug | Sorafenib | Approved | ||
In-vitro Model | SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
Hep-G2.215 (Hep-G2.215 were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences) | ||||
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 | |
7721 (Human hepatic malignant cell line) | ||||
In-vivo Model | HCC-LM3 cells transfected with sh-NC and sh-RBM15B-3 were injected into the axilla or tail vein of mice. | |||
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Overexpression of RBM15B promotes HCC cell proliferation and invasion and induces sorafenib resistance in HCC cells. RBM15B is transcriptionally activated by YY1 and regulates the stability of Translocating chain-associated membrane protein 2 (TRAM2) mRNA in an m6A-dependent manner. | |||
Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
Target Regulator | RNA-binding motif protein 15B (RBM15B) | WRITER | ||
Target Regulation | Up regulation | |||
Responsed Drug | Sorafenib | Approved | ||
In-vitro Model | SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
Hep-G2.215 (Hep-G2.215 were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences) | ||||
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 | |
7721 (Human hepatic malignant cell line) | ||||
In-vivo Model | HCC-LM3 cells transfected with sh-NC and sh-RBM15B-3 were injected into the axilla or tail vein of mice. | |||
Sorafenib
[Approved]
In total 1 item(s) under this drug | ||||
Experiment 1 Reporting the m6A-centered Drug Response | [1] | |||
Response Summary | Overexpression of RBM15B promotes HCC cell proliferation and invasion and induces sorafenib resistance in HCC cells. RBM15B is transcriptionally activated by YY1 and regulates the stability of Translocating chain-associated membrane protein 2 (TRAM2) mRNA in an m6A-dependent manner. | |||
Target Regulator | RNA-binding motif protein 15B (RBM15B) | WRITER | ||
Target Regulation | Up regulation | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
In-vitro Model | SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens | CVCL_0525 |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
Hep-G2.215 (Hep-G2.215 were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences) | ||||
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
HCCLM3 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_6832 | |
7721 (Human hepatic malignant cell line) | ||||
In-vivo Model | HCC-LM3 cells transfected with sh-NC and sh-RBM15B-3 were injected into the axilla or tail vein of mice. | |||